UC San Diego School of Medicine
La Jolla, California 92093-0960
1 studies enrolling now · 3 studies all time
What they study most
Coronary Artery Disease, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Obstructive Hypertrophic Cardiomyopathy
Studies at this site
- A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
- Firehawk Rapamycin Target Eluting Coronary Stent North American Trial — Running, not enrolling
- Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis — Stopped early